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Streptococcus pneumoniae (S. pneumoniae), a commensal across the nasal passages,
is responsible for the majority of infectious pneumonia cases worldwide. Previous
studies have shown that hormonal factors may be influential in regulating S.
pneumoniae’s transition from a non-pathogen to a pathogenic state. The current study
investigated the effects of corticotropin-releasing hormone (CRH), a peptide hormone
involved in stress, on the pathogenicity of S. pneumoniae. Mice were infected with
CRH-treated S. pneumoniae via intranasal route, showing an increase in pulmonary
bacterial burden. We also quantified S. pneumoniae’s response to CRH through limited
serial dilutions and growth curve analysis. We demonstrated that CRH promotes S.
pneumoniae titer-dependent proliferation, as well as accelerates log-phase growth.
Results also showed an increase in pneumococcal-associated virulence protein A
virulence gene expression in response to CRH. These results demonstrate a role for
CRH in S. pneumoniae pathogenicity, thus implicating CRH in mediating the transition
of S. pneumoniae into a pathogenic state.
Keywords: Corticotropin releasing hormone, Streptococcus pneumoniae, pathogenicity, hormones, virulence,
commensal, respiratory
Introduction
Streptococcus pneumoniae (S. pneumoniae) contributes to the highest morbidity and mortality
rates worldwide (Laupland and Church, 2014; Oishi et al., 2014). Approximately $4.9 billion dollars
in healthcare cost is attributed to pneumonia in the United States (US; Reynolds et al., 2014). The
magnitude of this problem is underscored by the signiﬁcant mortality risks among hospitalized
patients ranging between 10 and 25% and increasing to 50% among patients 65 years and older
(Reynolds et al., 2014). Although increased antibiotic resistance plays a role, it does not entirely
explain the problem. For example, penicillin-resistance accounts for the majority of pneumococcal
resistance but attributes to only 4% of the total estimated healthcare costs (Laxminarayan, 2014).
Based on these statistics it is clear that a gap in knowledge exists, limiting our understanding of the
epidemiology of pneumonia caused by S. pneumoniae infection.
Among the 92 known serotypes of S. pneumoniae, few are considered virulent. Moreover,
invasive serotypes are not contagious under conditions within their disease states (e.g., pneumo-
nia, otitis media, and sepsis; Caierão et al., 2014; Del Amo et al., 2014; Feldman and Anderson,
2014). Rather, transmission of disease stems from the reservoir of resident asymptomatic pneu-
mococci along nasal passages, which, through unknown mechanisms, acquires pathogenic status.
It is believed that as a commensal, S. pneumoniae’s pathogenicity is largely inﬂuenced by complex
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symbiotic relationships within the host including commen-
sal competition, nutritional status, metabolic stress, mucosal-
associated immune responses, and hormonal signals (Alcaide
et al., 2012; Bailey, 2014; Cameron et al., 2014; Frydenborg et al.,
2014; Ishak et al., 2014). Neuropeptides in particular, have been
shown tomediate commensal ecosystems that impact disease sus-
ceptibility (Freestone et al., 2008; Schoen et al., 2014). Most of
what is understood linking microbial species’ response to stress
hormones relates to the neuroendocrine gut mucosal system
and its interaction with enteric bacterial species (Freestone and
Lyte, 2008; Lyte, 2014). However, mechanisms of disease between
hormonal factors and respiratory bacterial commensals remain
elusive.
Current knowledge of microorganisms’ response to neuroen-
docrine factors largely stem from studies deﬁning how dopamin-
ergic, catecholaminergic inotropes and cholinergic pathways
impact gut-associated microbes (Freestone and Lyte, 2008). For
example, catecholamines have been shown to stimulate toxin
release, motility, and attachment by Escherichia coli O157:H7,
Vibrio parahaemolyticus and other pathogens (Freestone et al.,
2007a). However, far less is known regarding hormonal signals’
impact on infectious disease across the respiratory tract. Two
recent studies have examined the role of catecholamine responses
by S. pneumoniae. Speciﬁcally, Sandrini et al. (2014) demon-
strated that norepinephrine (NE) could promote pneumococcal
growth and bioﬁlm formation. In addition, Gonzales et al. (2013)
showed that NE reduced lung adherence through iron binding as
a potential mechanism. This is consistent with the hypothesis that
bacterial species along the respiratory tract are responsive to hor-
monal factors as a potential inducer of pathogenicity. Due to high
mortality risks associated with respiratory disease caused by S.
pneumoniae, onemight expect as a critical need to understand the
role of neuroendocrine responses that mediate its pathogenicity
and that of other respiratory commensal organisms.
Corticotropin-releasing hormone (CRH) is a 41-amino acid
peptide produced in the hypothalamus and throughout the brain
where it plays a role in behavior and autonomic responses to
stress (Clynen et al., 2014; Gold, 2014; Kolasa et al., 2014).
CRH is also deﬁned by its induction of peripheral glucocorticoid
(e.g., cortisol in humans and corticosterone in mice) secretion,
known to suppress immune function (Quintanar and Guzman-
Soto, 2013; Uchoa et al., 2014). In contrast, CRH production also
occurs at peripheral sites and appears to be involved in inﬂam-
matory conditions associated with diseases such as rheumatoid
arthritis, cancer, colitis, and asthma (Vasiadi et al., 2012; Clynen
et al., 2014). Using a murine model of aversive stress and S. pneu-
moniae infection, we have previously demonstrated the expres-
sion of CRH in the lung, as well as its impact on host pulmonary
cellular immune and inﬂammatory responses (Gonzales et al.,
2008; Kim et al., 2011). The purpose of the current study was
to test whether CRH directly impacts S. pneumoniae virulence.
Findings presented here demonstrate that CRH directly increases
bacterial growth, a key characteristic of invasiveness. In support
of the observed increase in bacterial growth, we also demon-
strated inﬂuences of CRH on the regulation of pavA, a virulence
protein expressed by S. pneumoniae associated with the media-
tion of immune and inﬂammatory responses. Moreover, infection
of mice with CRH-treated S. pneumoniae resulted in greater
bacterial carriage in the lung.
Materials and Methods
Bacterial Strains
Streptococcus pneumoniae strain #6301 (ATCC, Manassas, VA,
USA) was used in all experiments. Prior to use, S. pneumoniae
was maintained in 30% glycerol frozen stock solutions (–80◦C).
Corticotropin-Releasing Hormone (CRH)
Human/rat recombinant CRH (Sigma–Aldrich, St. Louis, MO,
USA) was used in all experiments. CRH stock solutions were
stored at –20◦C in 20 μl aliquots until use.
Urocortin (UCN)
Urocortin (Sigma–Aldrich, St. Louis, MO, USA), a related CRH
homolog peptide, was used as a relevant negative control. UCN
stock solutions were stored at –20◦C in 2 ml aliquots until use.
Mice
Female CD1 strain (Harlan Laboratories, Houston, TX, USA)
between six and 8 weeks of age were used in all in vivo experi-
ments. Mice were maintained in sterile conditions and provided
food and water ad libitum. For infection studies, mice were
anesthetized by intraperitoneal injection of ketamine/xylazine
solution (50 mg/kg ketamine and 16 μg/kg xylazine for a total
volume of 0.2 ml). The University of North Texas Health Science
Center’s Institutional Animal Use Committee (IACUC) approved
all studies.
In Vivo Determination of CRH-Treated
S. pneumoniae Pathogenesis
Brieﬂy, frozen stock cultures were spread onto blood agar plates
and incubated for 18 h at 37◦C and 5% CO2 to achieve mid-log
phase growth. Cultures were suspended in a 50/50 Brain–Heart
Infusion (BHI; EMD Chemicals Inc., Darmstadt, Germany) and
Phosphate Buﬀered Saline (PBS; Life Technologies, Carlsbad,
CA, USA) broth mixture. Subsequent bacterial suspensions were
adjusted to an optical density (OD) of 1.0 containing approxi-
mately 1 × 108 bacterial cells.
Prior to infection, bacterial cells were diluted to 1 × 105
cells of S. pneumoniae and were exposed to 2.1 × 10−4 mM/μl
of CRH overnight at 37◦C and 5% CO2. S. pneumoniae was
collected and diluted to an infection dose of 2.0 × 105 CFUs
(LD50). Subsequently, anesthetized mice (N = 5/group) were
administered CRH-treated (CRH-Sp) or untreated S. pneumo-
niae (Sp; LD50) by intranasal route. Eighteen hours following
infection, anesthetized mice were euthanized to compare bac-
terial carriage in lungs of CRH-Sp versus Sp-infected mice
as previously described. Speciﬁcally, lungs were harvested and
homogenized in sterile cold PBS (Life Technologies, Carlsbad,
CA, USA). Ten-fold serial dilutions of lung homogenates were
plated in duplicates onto blood agar plates and incubated at 37◦C
overnight. Colonies on plates were enumerated, and the results
were expressed as log10 CFU per μl.
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Quantitation of S. pneumoniae in Response
to CRH by Limited Dilution CFU Analysis
Streptococcus pneumoniae strain #6301 (ATCC, Manassas, VA,
USA) was grown overnight to achieve mid-log phase cultures on
Blood Agar plates. S. pneumoniaewas collected and suspended in
a 50/50 BHI and PBS broth mixture. Ten-fold dilutions of a start-
ing cell number of 1.3 × 106 were seeded in sterile 96-well ﬂat
bottom plates in the presence or absence of CRH at concentra-
tions of 2.1 × 10−4 mM/μl and 4.0 × 10−4 mM/μl, respectively.
In addition, 4.0 × 10−4 mM/μl UCN was introduced to bacterial
cultures to serve as a negative control. Aliquots (8 μl) of bacterial
suspensions with or without CRH or UCN were plated on blood
agar plates and incubated at 37◦C overnight. Colonies on plates
were enumerated, and the results were expressed as log10 CFU
per μl. All experiments were performed in duplicate.
Growth Curve Determination in Response to
CRH
Bacterial stock of S. pneumoniae was prepared by adding 50 μl
of bacteria from frozen stock to 1950 μl of sterile BHI broth. The
mixture was incubated overnight at 37◦C (5%CO2). Twenty-four
hours later absorbance of the overnight culture was determined
and adjusted to 0.2 at OD600 in BHI. A series of duplicate
tubes were prepared containing 1950 μl and 50 μl of S. pneu-
moniae in the presence or absence of 2.1 × 10−4mM/μl CRH
and incubated at 37◦C (5% CO2). Duplicate absorbance readings
(OD600) of bacterial cultures were taken every 30 min. over a 9 h
time period. Absorbance readings were plotted against time to
generate bacterial growth curves.
Gene Expression Profiling by Quantitative
Real-Time Polymerase Chain Reaction
(qRT-PCR)
Streptococcus pneumoniae from freezer stock was plated
overnight at 37◦C (5% CO2). After an 18 h of incubation, bac-
teria were collected and suspended in BHI and the absorbance
was read and adjusted to 1 (OD600 = 1.0). Bacterial cells were
incubated overnight at 37◦C (5% CO2) in presence or absence of
2.1 × 10−4 mM/μl CRH.
Bacterial RNA Extraction
Eighteen hours after incubation, S. pneumoniae from represen-
tative experimental conditions were collected in separate labeled
tubes using sterile BHI broth. Absorbance of each sample was
read and adjusted to an OD600 = 1.0, representing 108–109 cell
density. RNA extraction from bacterial cells was performed using
a RiboPure RNA Puriﬁcation Kit (Life Technologies, Carlsbad,
CA, USA).
Reverse Transcription and qRT-PCR
cDNA was generated using a starting Total RNA concen-
tration of 1 μg per reaction and MLV (Molony murine
leukemia virus) reverse transcriptase (Promega Corp., Madison,
WI, USA). After cDNA synthesis, real-time PCR was per-
formed using SYBR green-based ampliﬁcation techniques.
PCR was performed in a 20 μl reaction volume using
the StepOne system (Applied Biosystems Inc., Foster City,
TABLE 1 | List of primer sequences and target gene.
Sequence
House keeping Gene1
16S rRNA-Forward (5′–3′ ) TGAGTTAACCGTAAGGAGCCA
16S rRNA-Reverse (3′–5′) TCACCCCAATCATCTATCCCA
pavA (Pneumococcal adherence and virulence factor A)2
Forward (5′–3′ ) GGTCGCATCCAGAAAATC
Reverse (3′–5′ ) AGAAAGGAGCAGGCGATG
1Gonzales et al. (2013); 2Cope et al. (2011).
FIGURE 1 | Corticotropin-releasing hormone (CRH)-treated
Streptococcus pneumoniae increases mice lung carriage. We assessed
whether or not exposing mice to S. pneumoniae (105 cells), previously treated
or untreated with CRH, would result in bacterial burden for the mice. Mice
(N = 5) treated with previously exposed to CRH bacteria (2.0 × 105 cells)
showed an increase in lung carriage compared to the unexposed group. Bar
graphs represent the mean ± SE of (N = 5) the number of CFUs in lungs.
Asterisks (∗) indicate significant (P ≤ 0.05) differences between experimental
groups.
CA, USA). The expression of the housekeeping gene 16s
rRNA was used as an internal control to normalize tar-
get gene expression between samples. Pneumococcal adher-
ence and virulence factor A (pavA) gene expression in
bacterial cells was calculated using the following formula:
CT =CT(target gene) − CT(16s rRNA) (Kim et al., 2011)
Data was calculated by subtracting ΔΔCT of control group
from the CRH-treated group for each target gene. Data was
expressed as the fold diﬀerence between pavA by normaliz-
ing the expression of untreated target genes as 1. Selected tar-
get and house keeping gene primer sets; pavA and 16s rRNA
were purchased from Life Technologies, Carlsbad, CA, USA
(Table 1).
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FIGURE 2 | Titer-dependent effects of CRH on S. pneumoniae
colony formation. Ten-fold serial dilutions of S. pneumoniae were
incubated in the absence (A) or presence of two concentrations of
CRH, 2.1 × 10−4 μM (B) and 4.0 × 10−4 μM, (C) and plated on
blood agar plates. Data shown is representative of two independent
experiments (A). (B) Represents quantitation of the aforementioned
results in (A). Bars represent mean (N = 3) ± SE. Asterisks (∗)
indicate significant (P ≤ 0.05) differences between experimental groups.
White bars denote unexposed S. pneumoniae, gray and black bars
denote S. pneumoniae exposed to two different CRH concentrations,
4.0 × 10−4 μM and 2.0 × 10−4 μM, respectively (B). (C) Highlights
the specificity of CRH compared to its homolog UCN. Bars represent
mean (N = 3) ± SE. Asterisks (∗) indicate significant (P ≤ 0.05)
differences between experimental groups.
Statistical Analysis
Statistical analysis was performed using GraphPad PrismVersion
6.0 (GraphPad Software, San Diego, CA, USA). For multi-
experimental group analysis, data were subjected to one-way and
two-way ANOVA (analysis of variance) followed by post hoc tests
(Newman–Keuls and Bonﬀeroni) for group diﬀerences. Other
results were analyzed using t-test where indicated. All data are
expressed as means ± SEM. A P-value of ≤ 0.05 was considered
signiﬁcant.
Results
CRH-Treated S. pneumoniae Increases Lung
Carriage
We determined whether exposing S. pneumoniae to CRH would
impact its propensity to induce pulmonary infection. S. pneumo-
niae cultures were exposed to CRH (2.1× 10−4mM/μl) and used
for nasal infection. Bacterial colonization in the lungs of mice
was signiﬁcantly higher (P ≤ 0.05) in mice exposed CRH-treated
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FIGURE 3 | Corticotropin-releasing hormone accelerates log-phase
growth of S. pneumoniae. S. pneumoniae, CRH exposed
(2.1 × 10−4 μM/μl) vs. non-exposed, growth analysis was performed over a
period of 9 h. Asterisks (∗ ) indicate significant (P ≤ 0.05) differences observed
in the final bacterial mass during stationary phase. All experiments were
performed in duplicates.
FIGURE 4 | Streptococcus pneumoniae adhesion and virulence factors
increase in the presence of CRH. pavA gene expression was determined
by quantitative realtime PCR analysis of S. pneumoniae’s mRNA exposed to
CRH (N = 3). The analysis showed overexpression of the bacterium’s
adhesion and virulence gene (pavA) when compared to control genes.
Asterisks (∗ ) indicate significant (P ≤ 0.05) difference between CRH treated
(CRH-Sp) and non-CRH treated (Sp) bacterial groups.
S. pneumoniae (CRH-Sp) compared to untreated S. pneumoniae
(Sp; Figure 1).
CRH Promotes S. pneumoniae
Titer-Dependent Proliferation
The above results suggested that CRH directly promotes the
pathogenicity of S. pneumoniae by increased colonization in the
lung. We assessed the eﬀect of CRH on S. pneumoniae pro-
liferation controlling for bacterial titer and variation in CRH
concentration. S. pneumoniae colony forming units (CFUs) were
signiﬁcantly higher (P ≤ 0.05) given exposure to both concen-
trations of CRH at each titer of S. pneumoniae. In contrast to
un-treated cultures of S. pneumoniae, CRH signiﬁcantly sus-
tained detection of CFUs at the lowest titer (8th-fold dilution;
Figures 2A,B). To conﬁrm speciﬁcity of CRH’s eﬀect, addi-
tional experiments were performed whereby S. pneumoniae was
exposed to the CRH homolog UCN. Lower concentrations of
UCN (2.1 × 10−4mM/μl) were also used in testing. No diﬀer-
ences in CFUs were observed in the presence of UCN at diﬀerent
concentrations compare to untreated S. pneumoniae (Figure 2C).
CRH Accelerates Log-Phase Growth of
S. pneumoniae Growth
We compared the bacterial growth curve in presence and absence
of CRH. A signiﬁcant diﬀerence (P ≤ 0.05) was observed in
bacteria exposed to CRH during log phase growth. In addition,
signiﬁcant diﬀerences in the ﬁnal bacterial mass were observed
during stationary growth phase (Figure 3).
CRH Increases Pneumococcal Adherence
and Virulence Factor A (pavA) mRNA Gene
Expression by S. pneumoniae
PavA gene expression is found to modulate bacterial adhesion,
invasion, and inﬂammation associated with septicemia (Pracht
et al., 2005). Figure 4 demonstrates a signiﬁcant (P ≤ 0.05)
increase in pavA mRNA expression by S. pneumoniae exposed
to CRH, compared to untreated controls as determined by quan-
titative realtime PCR.
Discussion
This study expands upon an emerging area of research that
seeks to deﬁne hormonal signals as determinants for pathogenic
transformation of commensal bacterial species (Freestone, 2013;
Lyte, 2014). We demonstrate how CRH, a hormonal mediator
of central and peripheral neuro-immune axes, works in medi-
ating virulence-associated factors of the upper respiratory tract
commensal S. pneumoniae. Moreover, our previous studies estab-
lished the role of CRH in regulating experimental pneumonia
and sepsis caused by S. pneumoniae (Gonzales et al., 2008; Kim
et al., 2011), implicating it in mediation of host cellular immune
and inﬂammatory responses. Research deﬁning CRH and other
hormonal factors as direct modiﬁers of respiratory commensal
species remain unknown.
A commensal organism’s ability to sense a change in its envi-
ronment is essential for its survival. Prevalent hormonal stress
signals identiﬁed to inﬂuence bacterial phenotype and func-
tion include catecholamines, NE and epinephrine (Freestone
and Lyte, 2010). Studies demonstrated that in vitro, NE and
epinephrine promote microorganism’s growth, metabolic poten-
tial, nutritional status, and bioﬁlm formation (Neal et al., 2001;
Lyte et al., 2003; Freestone et al., 2007b; Yang et al., 2014b)
furthermore suggesting that catecholamines, and possibly other
hormonal stress factors, are inﬂuential regulators of microbial
virulence (Li et al., 2009; Lucas et al., 2012; Pande et al., 2014).
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However, aforementioned hormonal eﬀects have been primarily
a focus of bacterial species resident in gut mucosa.
Previous studies have been associated with the activation of
stress factors with disease pathogenesis along respiratory tis-
sues (Lim et al., 2014; Runeson-Broberg and Norback, 2014;
Tomljenovic et al., 2014; Yang et al., 2014a). Utilizing an exper-
imental model of aversive stress and S. pneumoniae infection,
we demonstrated CRH’s ability to regulate disease severity by
controlling cellular immune and inﬂammatory responses (Kim
et al., 2011). Notably, our studies demonstrated that inhibiting
CRH from binding its target receptor CRHR1 caused increased
pneumonia and sepsis. We thus hypothesized that increasing
peripheral CRH levels allows for increased exposure to S. pneu-
moniae, potentially impacting its pathogenicity. In the current
study, we tested the possible direct eﬀects imparted by CRH
on the propensity of S. pneumoniae to cause disease, to inﬂu-
ence bacterial growth and to modulate pavA gene expression.
As shown in Figure 1, exposing S. pneumoniae cultures to CRH
prior to experimental infection produced greater pulmonary bac-
terial burden compared to infection with untreated cultures. This
ﬁnding suggested that independent of CRH’s impact on host cel-
lular immune function, disease severity could be elicited from S.
pneumoniae being directly exposed to CRH; thus supporting the
potential for S. pneumoniae to recognize and respond to CRH for
purposes of modulating its phenotype.
Possible mechanisms through which CRH could be impart-
ing its function were determined by testing its eﬀects on key
indicators of bacterial virulence (e.g., microorganisms’ growth).
We determined that CRH enhanced the growth phase kinet-
ics of S. pneumoniae (Figure 3), reinforcing earlier studies
demonstrating hormonal factors’ ability to modulate bacterial
growth (Freestone et al., 2007b; Seeley et al., 2013; Pande
et al., 2014). The ability of CRH to promote colony forma-
tion further substantiated its role in growth-associated vir-
ulence at signiﬁcantly lower bacterial titers (Figures 2A–C).
Ongoing studies using a clinical invasive serotype 3 pneu-
mococcal strain were more invasive in the presence of CRH
interpreted by its ability to reestablish secondary colony for-
mation from primary bioﬁlms (Thapa et al., unpublished data).
These ﬁndings suggest a role for CRH in regulating mechanisms
of invasiveness associated with high risk for pneumonia and
sepsis.
The studies presented here highlight for the ﬁrst time the abil-
ity of CRH to serve as a catalyst for S. pneumoniae virulence.
Mechanisms of action have been identiﬁed as basis for S. pneumo-
niae’s response to stress hormonal signals. Catecholamines play a
role in the process of Fe-transport across bacterial membranes
and making Fe valence available for enriched metabolic pro-
cesses (Freestone et al., 2000, 2003). NE, a known siderophore,
enhances iron availability to S. pneumoniae, thus promoting
bacterial growth and virulence (Kinney et al., 2000; Gonzales
et al., 2013). Whereas siderophore processing cascades of Gram-
negative species have been understood (Seeley et al., 2013), they
remain unknown for the Gram-positive bacterial species. Future
studies should address how CRH is sensed and processed by S.
pneumoniae and other bacterial species.
The inability to tailor inﬂammatory responses hinders sig-
niﬁcant advances to improve disease outcomes associated with
infectious pneumonia. Despite the current use of systemic cor-
ticosteroids as standard adjunctive treatment to reduce inﬂam-
matory reactions in cases of pneumonia (Steel et al., 2013; Sibila
et al., 2014), mortality and morbidity rates remain high (Lin
et al., 2010; Moon et al., 2012; Peterkovic et al., 2012), rais-
ing questions of their beneﬁt (Ramsey and Gorman, 2014; Sibila
et al., 2014). Stress-induced release of endogenous glucocorti-
coids or other hormones may negatively impact adjunctive cor-
ticosteroid use. Currently there are few studies demonstrating
the potential relationships between glucocorticoids and bacte-
rial pathogenicity. Pseudomonas aeruginosa was found to pro-
duce a protease factor that inhibits cortisol-binding globulin
as a mechanism of blocking plasma cortisol transport (Simard
et al., 2014). In addition, Verbrugghe et al. (2011) showed that
cortisol can directly impact bacterial functioning. They demon-
strated that Salmonella typhimurium’s proliferation was increased
within macrophages exposed to cortisol in pigs, but not in the
presence of catecholamines (Verbrugghe et al., 2011). In the
current study, we found that CRH increased pavA (modulator
of bacterial adherence and inﬂammation) gene expression by
S. pneumoniae (Figure 4), thus highlighting the role of CRH in
bacterial-associated inﬂammatory responses. While mechanisms
deﬁning interactions between the central nervous and immune
systems have been proved important for host susceptibility and
resolution of disease (Dhabhar, 2014), few therapies take into
account the direct inﬂuence of stress factors on bacterial physi-
ology. In total, our results provide evidence in support of CRH to
directly inﬂuence S. pneumoniae virulence. However, limitations
requiring further investigation such as the direct abrogation of
CRH-mediated responses will be key to understanding the mech-
anistic relationships between CRH and its pathogenicity. Such
studies could lead to novel approaches to reduce the onset of
disease.
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